Mesothelioma: all 475 studies
Page 1 of 5. Open to participants first (75), then studies with results posted, then the rest; newest registration first within each.
- Implantable Microdevices for in Situ Evaluation of Drug Responses in Lung CancerNot yet recruitingNCT07892300Early Phase 1
- A Phase 3 Trial in Advanced Epithelioid MesotheliomaNot yet recruitingNCT07824986Phase 3
- A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid TumorsRecruitingNCT07705334Phase 1
- FAPI PET Imaging - An Exploratory StudyNot yet recruitingNCT07705074Phase 1/2
- SELECTmeso A Trial for Patients With Relapsed Malignant Mesothelioma SELECTmeso1 A Trial of BMS-986504 in Patients With MTAP-deficient Relapsed MesotheliomaNot yet recruitingNCT07602946Phase 2
- A 2-part Phase 1/2 Open-label Trial on ODM-212RecruitingNCT07563738Phase 1/2
- Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced MesotheliomaNot yet recruitingNCT07514793Phase 2
- Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal MesotheliomaRecruitingNCT07510815Phase 1/2
- An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.Not yet recruitingNCT07420010Early Phase 1
- A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsRecruitingNCT07277413Phase 1
- Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant MesotheliomaNot yet recruitingNCT07131345Phase 1/2
- Partial Pleurectomy (Surgery) for Unresectable Pleural MesotheliomaRecruitingNCT07126509Not applicable
- An International Study on Pediatric Patients With Rare Tumors.RecruitingNCT07072143
- Prospective Data Collection Initiative on Thoracic MalignanciesRecruitingNCT06996249
- First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.RecruitingNCT06946498Not applicable
- Hemithoracic Arc Radiotherapy Post Pleural DecorticationRecruitingNCT06910449Not applicable
- Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE VariaTionSRecruitingNCT06886672
- Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including MesotheliomaRecruitingNCT06885697Phase 1
- A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) ProductsEnrolling by invitationNCT06885424
- Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural MesotheliomaRecruitingNCT06875076Phase 2
- A Study of MT027 in Patients with Pleural Malignant TumorsRecruitingNCT06726564Phase 1
- Lead-212 PSV359 Therapy for Patients With Solid TumorsRecruitingNCT06710756Phase 1/2
- Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid TumorsNot yet recruitingNCT06652529Phase 1
- Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeMRecruitingNCT06543069Phase 2
- Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICURecruitingNCT06538376Not applicable
- New Preclinical and Clinical Approaches to MesotheliomaRecruitingNCT06536179
- 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer DetectionRecruitingNCT06503146Phase 2
- EXTRA-Meso (EXercise TheRApy in Mesothelioma) FeasibilityRecruitingNCT06491784Not applicable
- A Study of Sacituzumab Govitecan in People With MesotheliomaRecruitingNCT06477419Phase 2
- A Study of BGC515 Capsules in Subjects With Advanced Solid TumorsRecruitingNCT06452160Phase 1
- Ga-68 FAPI PET Before ImmunotherapyRecruitingNCT06451536Not applicable
- A Study of VET3-TGI in Patients With Solid TumorsRecruitingNCT06444815Phase 1
- Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural MesotheliomaNot yet recruitingNCT06416930Phase 2
- Evaluation of Response by FLT PET in MesotheliomaRecruitingNCT06410625Not applicable
- Exercise to Boost Immunity in Advanced CancerNot yet recruitingNCT06310993Not applicable
- Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin AdministrationRecruitingNCT06281860Phase 1
- Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid TumorsRecruitingNCT06256055Phase 1
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsRecruitingNCT06239194Phase 1/2
- GPC3/Mesothelin-CAR-γδT Cells Against CancersRecruitingNCT06196294Phase 1
- A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal MesotheliomaRecruitingNCT06057935Phase 2
- A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionRecruitingNCT06051695Phase 1/2
- Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural MesotheliomaRecruitingNCT06031636
- Folinic Acid for Prevention of Pemetrexed-induced ToxicityRecruitingNCT06010277Phase 4
- Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage MesotheliomaRecruitingNCT05960773Phase 2
- Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for MesotheliomaRecruitingNCT05932199Phase 1/2
- Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural MesotheliomaRecruitingNCT05930665Phase 2
- Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural InterventionRecruitingNCT05910112
- Studying the Clinical Trial Experiences of Patients With MesotheliomaNot yet recruitingNCT05819580
- Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsRecruitingNCT05732831Phase 1/2
- MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKIRecruitingNCT05730816Phase 2
- Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid TumoursNot yet recruitingNCT05698238Phase 1
- First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor MalignanciesRecruitingNCT05627960Phase 1
- Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)RecruitingNCT05579366Phase 1/2
- AMT-151 in Patients With Selected Advanced Solid TumoursRecruitingNCT05498597Phase 1
- OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint InhibitionNot yet recruitingNCT05425576Phase 2
- Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or LymphomasRecruitingNCT05415098Phase 1
- Phase 1 Study of MRTX1719 in Solid Tumors With MTAP DeletionRecruitingNCT05245500Phase 1
- Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)RecruitingNCT04996017Phase 3
- Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell ManufacturingRecruitingNCT04981119
- Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural MesotheliomaRecruitingNCT04823741
- Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition SyndromeRecruitingNCT04792463
- Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural MesotheliomaNot yet recruitingNCT04713761Phase 2
- Study to Evaluate VT3989 in Patients With Metastatic Solid TumorsRecruitingNCT04665206Phase 1/2
- Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin ToxicityRecruitingNCT04631731Phase 1/2
- Olaparib in Patients With HRD Malignant MesotheliomaRecruitingNCT04515836Phase 2
- Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition SyndromeRecruitingNCT04431024
- Stereotactic Magnetic Resonance Guided Radiation TherapyRecruitingNCT04115254Not applicable
- Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1RecruitingNCT03830229
- Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic BiomarkersRecruitingNCT03683680Not applicable
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaRecruitingNCT03556228Phase 1/2
- A Phase I/II Study of Regorafenib Plus Avelumab in Solid TumorsRecruitingNCT03475953Phase 1/2
- Peritoneal Surface Malignancies - Characterization, Models and Treatment StrategiesRecruitingNCT02073500
- Integrated Cancer Repository for Cancer ResearchRecruitingNCT02012699
- Tissue Procurement and Natural History Study of Patients With Malignant MesotheliomaRecruitingNCT01950572
- Molecular Analysis of Thoracic MalignanciesEnrolling by invitationNCT01385722
- A Study to Investigate 14C-bemcentinib in Healthy Male SubjectsCompletedNCT06469138Phase 1Results posted
- A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing CancerTerminatedNCT05451849Phase 1/2Results posted
- A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid TumorsTerminatedNCT05070247Phase 1/2Results posted
- KZR-261 in Subjects With Advanced Solid MalignanciesTerminatedNCT05047536Phase 1Results posted
- A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal MesotheliomaCompletedNCT05041062Phase 2Results posted
- Study of the Efficacy and Safety of the Bintrafusp Alfa in Previously Treated Advanced Malignant Pleural MesotheliomaCompletedNCT05005429Phase 2Results posted
- Alvopem® (Pemetrexed) Safety AssessmentCompletedNCT04843007Results posted
- Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant MesotheliomaTerminatedNCT04840615Phase 1Results posted
- Effects of Itraconazole and Rifampin on the Blood Tazemetostat LevelsCompletedNCT04537715Phase 1Results posted
- DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural MesotheliomaCompletedNCT04334759Phase 3Results posted
- Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsTerminatedNCT04234113Phase 1Results posted
- Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural MesotheliomaTerminatedNCT04166734Phase 1Results posted
- Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural MesotheliomaTerminatedNCT04158141Phase 3Results posted
- A Study of Pembrolizumab in Combination With Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma (MPM) (MK-3475-A17)CompletedNCT04153565Phase 1Results posted
- Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid TumorsCompletedNCT04034238Phase 1Results posted
- Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced MalignanciesTerminatedNCT03881488Phase 1Results posted
- PF-06952229 Treatment in Adult Patients With Advanced Solid TumorsTerminatedNCT03685591Phase 1Results posted
- Anti-Mesothelin Immunotoxin LMB-100 Followed by Pembrolizumab in Malignant MesotheliomaTerminatedNCT03644550Phase 2Results posted
- Olaparib in People With Malignant MesotheliomaCompletedNCT03531840Phase 2Results posted
- Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated MesotheliomaTerminatedNCT03502746Phase 2Results posted
- Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal MesotheliomaTerminatedNCT03436732Phase 1Results posted
- Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant MesotheliomaCompletedNCT03399552Phase 1/2Results posted
- Pevonedistat Alone and in Combination With Chemotherapy in Patients With MesotheliomaTerminatedNCT03319537Phase 1/2Results posted
- Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal CarcinomasTerminatedNCT03233724Phase 1/2Results posted
- A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)CompletedNCT03207347Phase 2Results posted